TScan Therapeutics
TScan Therapeutics is harnessing novel T cell systems to extend the promise of immunotherapy.
Based based in United States, TScan Therapeutics works in life sciences, founded in 2018.
TScan Therapeutics is positioned in life sciences, a segment that rewards a clear, focused offering.
The company is recorded as being based in United States.
Directory data places it at the GV portfolio company stage.
| Sector | Life Sciences |
|---|---|
| Country | United States |
| Founded | 2018 |
| Stage | GV portfolio company |
Website: www.tscan.com
Sign in to view the contact information we hold for TScan Therapeutics.
Create a free account
Create a free account